APOE3ch alleviates Aβ and tau pathology and neurodegeneration in the human APP cerebral organoid model of Alzheimer's disease.
作者信息
Liu Hang, Mei Fan, Ye Rongrong, Han Xinyu, Wang Shudan, Ding Yan, Zhi Yun, Pang Keliang, Guo Wei, Lu Bai
机构信息
School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University-Peking University Joint Center for Life Sciences, Tsinghua University, Beijing, China.
Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
出版信息
Cell Res. 2024 Jun;34(6):451-454. doi: 10.1038/s41422-024-00957-w. Epub 2024 Apr 12.
Abstract
摘要
相似文献
1
APOE3ch alleviates Aβ and tau pathology and neurodegeneration in the human APP cerebral organoid model of Alzheimer's disease.
Cell Res. 2024 Jun;34(6):451-454. doi: 10.1038/s41422-024-00957-w. Epub 2024 Apr 12.
2
Cerebral organoids with chromosome 21 trisomy secrete Alzheimer's disease-related soluble aggregates detectable by single-molecule-fluorescence and super-resolution microscopy.
Mol Psychiatry. 2024 Feb;29(2):369-386. doi: 10.1038/s41380-023-02333-3. Epub 2023 Dec 15.
3
Increase in Tau Pathology in P290S Knock-In Mice Crossed with Mice.
eNeuro. 2022 Dec 20;9(6). doi: 10.1523/ENEURO.0247-22.2022. Print 2022 Nov-Dec.
4
Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
BMC Neurosci. 2019 Mar 20;20(1):13. doi: 10.1186/s12868-019-0496-6.
5
Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Acta Neuropathol. 2019 Dec;138(6):913-941. doi: 10.1007/s00401-019-02053-5. Epub 2019 Aug 14.
6
Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
eNeuro. 2017 Mar 27;4(2). doi: 10.1523/ENEURO.0149-16.2017. eCollection 2017 Mar-Apr.
7
The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App mice.
Alzheimers Res Ther. 2024 Jan 2;16(1):4. doi: 10.1186/s13195-023-01375-7.
8
House dust mite-induced asthma exacerbates Alzheimer's disease changes in the brain of the App mouse model of disease.
Brain Behav Immun. 2024 Oct;121:365-383. doi: 10.1016/j.bbi.2024.07.038. Epub 2024 Jul 29.
9
Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
J Neurosci. 2016 Sep 14;36(37):9647-58. doi: 10.1523/JNEUROSCI.1899-16.2016.
10
Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Neurobiol Dis. 2016 Jan;85:187-205. doi: 10.1016/j.nbd.2015.11.005. Epub 2015 Nov 10.
引用本文的文献
1
Stem cell and CRISPR/Cas9 gene editing technology in Alzheimer's disease therapy: from basic research to clinical innovation.
Front Genome Ed. 2025 Aug 26;7:1612868. doi: 10.3389/fgeed.2025.1612868. eCollection 2025.
2
Navigating Brain Organoid Maturation: From Benchmarking Frameworks to Multimodal Bioengineering Strategies.
Biomolecules. 2025 Aug 4;15(8):1118. doi: 10.3390/biom15081118.
3
Human cerebral organoids: Complex, versatile and human-relevant models of neural development and brain diseases.
Neural Regen Res. 2025 May 6. doi: 10.4103/NRR.NRR-D-24-01639.
4
Animal models of Alzheimer's disease: Current strategies and new directions.
Zool Res. 2024 Nov 18;45(6):1385-1407. doi: 10.24272/j.issn.2095-8137.2024.274.
5
Preclinical research (on rare diseases): we need to talk about health equity.
Mamm Genome. 2024 Oct 26. doi: 10.1007/s00335-024-10080-1.
6
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.
Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x.
7
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies.
Transl Neurodegener. 2024 Aug 6;13(1):40. doi: 10.1186/s40035-024-00429-6.
本文引用的文献
1
APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread.
Cell. 2024 Jan 18;187(2):428-445.e20. doi: 10.1016/j.cell.2023.11.029. Epub 2023 Dec 11.
2
The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation.
Nat Neurosci. 2023 Dec;26(12):2104-2121. doi: 10.1038/s41593-023-01480-8. Epub 2023 Nov 13.
3
Emerging diagnostics and therapeutics for Alzheimer disease.
Nat Med. 2023 Sep;29(9):2187-2199. doi: 10.1038/s41591-023-02505-2. Epub 2023 Sep 4.
4
Genetics of human brain development.
Nat Rev Genet. 2024 Jan;25(1):26-45. doi: 10.1038/s41576-023-00626-5. Epub 2023 Jul 28.
5
Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration.
Nat Rev Neurol. 2023 Jul;19(7):395-409. doi: 10.1038/s41582-023-00822-1. Epub 2023 Jun 12.
6
Human cerebral organoids - a new tool for clinical neurology research.
Nat Rev Neurol. 2022 Nov;18(11):661-680. doi: 10.1038/s41582-022-00723-9. Epub 2022 Oct 17.
7
ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias.
Neuron. 2022 Apr 20;110(8):1304-1317. doi: 10.1016/j.neuron.2022.03.004. Epub 2022 Mar 16.
8
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.
Nat Rev Neurosci. 2022 Jan;23(1):53-66. doi: 10.1038/s41583-021-00533-w. Epub 2021 Nov 23.
9
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments.
Cell Res. 2022 Feb;32(2):157-175. doi: 10.1038/s41422-021-00582-x. Epub 2021 Nov 17.
10
Leveraging preclinical models for the development of Alzheimer disease therapeutics.
Nat Rev Drug Discov. 2020 Jul;19(7):447-462. doi: 10.1038/s41573-020-0065-9. Epub 2020 Apr 8.
Zotero 插件